Buys
Open market- Shares
- +8,600
- Avg price
- $2.90
- Total value
- +$24,940
Robert Eugene Anderson Jr. - Director at FILANA THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- FLNA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Robert Eugene Anderson Jr. in FILANA THERAPEUTICS, INC.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +8,600
- Share %
- 100%
- Total value
- +$24,940
Reported holdings for Robert Eugene Anderson Jr. in FILANA THERAPEUTICS, INC.
Form 4 holding
Director
CASSAVA SCIENCES INC
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 26,500
- Estimated value
- $168,700
- Report date
- 23 May 2025
- Price
- $16.87
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
CASSAVA SCIENCES INC
- Security class
- Common Stock
- Shares / value
- 8,600
- Estimated value
- $24,940
- Report date
- 24 Nov 2025
- Price
- $2.90
- Ownership
- Direct
Transaction history for Robert Eugene Anderson Jr. in FILANA THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.